Sen. Hassan grills pharma executive over marketing of powerful opioids
Click here to view this article at the source publication
U.S. Sen. Maggie Hassan, D-NH, pounced on a pharmaceutical drug maker during a Senate hearing Tuesday, citing New Hampshire lawsuits that allege the improper marketing of opioids.
Executives with seven of the top drug makers faced tough questioning during a Senate Finance Committee hearing called to address the rising costs of prescription drugs.
But Hassan, newly named to this panel, shifted the topic to opioid addiction.